Your search for comorbidities returned 41 results

Researchers assessed the clinical usefulness of specific biomarkers in risk stratification for vascular complications Identifying biomarkers that predict risk for pulmonary hypertension or ischemic digital lesions may be useful in monitoring the development of systemic sclerosis in patients.

Women who smoke may be at higher risk of developing abdominal aortic aneurysm compared with men who do not smoke.

In patients hospitalized for COPD exacerbation, the presence of atrial fibrillation may increase the risk of in-hospital mortality.

Researchers sought to assess the risk for major cardiovascular events and death in patients with rheumatoid arthritis (RA) vs those without RA who were referred for cardiac computed tomography for chest pain.

Patients with atrial fibrillation who use anticoagulants and have a history of gastrointestinal bleeding may be at higher risk for subsequent major gastrointestinal bleeding.

The duration of carotid blood flow reversal during transcarotid artery revascularization for carotid bifurcation stenosis was not found to affect the rate of stroke, myocardial infarction, or death.

The risk for a cardiac event was found to be greater in patients with peripheral artery disease vs coronary artery disease.

The long-term risk for a venous thromboembolism event was found to be associated with the occurrence of heart failure with preserved or reduced ejection fraction, and with left ventricular remodeling.

The presence of hyperlipidemia following hospitalization for acute myocardial infarction or acute decompensated heart failure may be associated with reduced mortality.

Patients with vs without chronic kidney disease were found to have more comorbidities and complex lesions after receiving new-generation drug-eluting stents.